eBulletin Newsletter

NCCN Flash Updates: NCCN Templates Updated for Systemic Mastocytosis

NCCN has published updates to the NCCN Chemotherapy Order Templates (NCCN Templates^®) for Systemic Mastocytosis and Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions to reflect the currently published NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) for Systemic Mastocytosis v3.2024 and Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions v1.2024.

• Changes to the Indication section have been made on the following NCCN Templates^®:
  • MLNE5: Imatinib
•  References have been updated on the following templates:
  • SM6: PEGinterferon alfa-2a
  • SM7: Avapritinib
  • MLNE12: Avapritinib
• Changes to the Chemotherapy Regimen section have been made on the following templates:
  • SM2: Imatinib
  • MLNE1: Bosutinib
  • MLNE5: Imatinib
  • MLNE8: PONATinib
• Drug information notes for the following agents have been updated in the Supportive Care, Monitoring and Hold Parameters, and/or Safety Parameters and Special Instructions sections:
  • Avapritinib
  • PONAtinib

For the complete updated versions of the NCCN Guidelines, NCCN Guidelines with NCCN Evidence Blocks™, the NCCN Drugs & Biologics Compendium (NCCN Compendium^®), the NCCN Biomarkers Compendium^®, the NCCN Chemotherapy Order Templates (NCCN Templates^®), the NCCN Radiation Therapy Compendium™, and the NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™), please visit NCCN.org.

To view the NCCN Guidelines for Patients^®, please visit NCCN.org/patientguidelines.

Free NCCN Guidelines apps for iPhone, iPad, and Android devices are now available! Visit NCCN.org/apps.

About NCCN Flash Updates™

NCCN Flash Updates™ is a subscription service from NCCN that provides timely notification of updated and new information appearing in the NCCN Guidelines, the NCCN Compendium^®, and other NCCN Content.

Subscribe to NCCN Flash Updates™

Third Party Content: The NCCN Content may contain content (such as figures, tables or illustrations) that NCCN licenses from third parties as displayed on NCCN Third Party Content site: private.filesanywhere.com/fs/v.aspx?v=8a6d65cfa19ea4bda0a3&C=6241. Licensee shall be solely responsible for obtaining permissions from each such third party to use any such Third Party Content in the Permitted Works. 

Access information on permissions and licensing of NCCN Content

Users may unsubscribe from Flash Updates at any time by contacting us. NOTE: The subscription fee for NCCN Flash Updates™ is non-refundable.